Research use only, not for human consumption. Email [email protected]
← Research status explorer
Rebuild / Repair & longevity

Thymosin Alpha-1

Also known as: Zadaxin

Current research status Phase 3
Indication-specific clinical development
Preclinical
Phase 1
Phase 2
Phase 3
Approved Molecule*

Overview

Thymosin Alpha-1 is an immune-modulating thymic peptide studied for chronic infections, certain cancers and immune support. It is marketed in a number of countries as Zadaxin, though it does not hold FDA approval in the United States. Indication-specific Phase 3 trials have been conducted outside the US, including in hepatitis and sepsis-related research.

Last reviewed: September 2026